ReviewJournal of biomedical optics2026
Perspective on the current state of hyperspectral/multispectral imaging for minimally invasive surgery.
Review in Journal of biomedical optics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Minimally invasive surgery (MIS) offers substantial benefits to patients, including reduced trauma and faster recovery. However, it limits visual and tactile feedback, which can affect surgical decision-making. Hyperspectral and multispectral imaging (HSI/MSI) are imaging technologies with the potential to provide detailed, real-time tissue characterization, enhancing minimally invasive intraoperative guidance. Aim: This perspective aims to summarize the current state-of-the-art in the use of HSI/MSI in laparoscopy and endoscopy. It focuses on both technological development and clinical implementation, providing an overview of performance characteristics and translational state. Approach: A structured literature search was conducted to identify relevant studies. These were analyzed for key system specifications (spectral range, resolution, and acquisition speed) and clinical applications. The studies were further categorized using a "bench-to-bedside" framework to evaluate their level of translational progress. Results: The majority of studies fall within early translational stages (T1 to T2), with no reports of large-scale clinical trials. Most systems operate in the visible spectrum (450 to 650 nm), optimized for blood-related imaging. Applications include perfusion assessment, nerve visualization using short-wave infrared wavelengths, and tumor detection. Conclusions: HSI/MSI for MIS is a rapidly developing field with demonstrated potential across a range of applications. Continued research and validation are essential to transition these technologies from experimental use to routine surgical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.